Innate Pharma SA
For the period ended Oct 20, 2026. Filed Oct 20, 2026.
View on SEC.govAbout this filing
What a company based outside the US has published at home or sent to its shareholders. It is how many foreign companies share results and news between annual reports.
Oct 20, 2026 · Filed Oct 20, 2026
Use the contents to explore the available documents and sections.
IPHA$1.44+2.9%Stored close · as of Nov 6, 2026
Contents
Cover page
Show cover page
6-K 1 a261020_6k.htm 6-K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.